Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4–10 ng/ml?

被引：0
|
作者：
Ning Xu
Yu-Peng Wu
Dong-Ning Chen
Zhi-Bin Ke
Hai Cai
Yong Wei
Qing-Shui Zheng
Jin-Bei Huang
Xiao-Dong Li
Xue-Yi Xue
机构：
[1] First Affiliated Hospital of Fujian Medical University,Department of Urology
来源：
Journal of Cancer Research and Clinical Oncology | 2018年 / 144卷
关键词：
PIRADS; MpMRI; Prostate cancer; Prostate biopsy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：987 / 995
页数：8
相关论文
共 50 条
  • [21] IS PSA VELOCITY USEFUL FOR PROSTATE CANCER DETECTION OR PROGNOSTICATION IN MEN WITH A PSA > 10 NG/ML?
    Loeb, Stacy
    Roehl, Kimberly A.
    Catalona, William J.
    [J]. JOURNAL OF UROLOGY, 2009, 181 (04): : 811 - 811
  • [22] Prostate health index can stratify patients with Prostate Imaging Reporting and Data System score 3 lesions on magnetic resonance imaging to reduce prostate biopsies
    Leung, John Shung-Lai
    Ma, Wai-Kit
    Ho, Brian Sze-Ho
    Chun, Stacia Tsun-Tsun
    Na, Rong
    Zhan, Yongle
    Ng, Chi-Yuen
    Ip, Chi-Ho
    Ng, Ada Tsui-Lin
    Lam, Yiu-Chung
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2024, 26 (01) : 20 - 24
  • [23] Review of Prostate Imaging Reporting and Data System version 2
    Wahab, Shaun A.
    Verma, Sadhna
    [J]. FUTURE ONCOLOGY, 2016, 12 (21) : 2479 - 2494
  • [24] Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better?
    Sackett, Jonathan
    Choyke, Peter L.
    Turkbey, Baris
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2019, 212 (06) : 1244 - 1252
  • [25] Prospective evaluation of the utility of %p2PSA and the Prostate Health Index (PHI), in predicting prostate cancer in initial prostate biopsies of Singaporean men, with total PSA between 4.0 and 10 ng/mL
    Gauhaar, Vineet
    Tan, Guan Lim Lincoln
    Goh, Yen Seow Benjamin
    [J]. BJU INTERNATIONAL, 2015, 116 : 3 - 3
  • [26] Prospective evaluation of the utility of %P2psa and the Prostate Health Index (PHI), in predicting prostate cancer in initial prostate biopsies of Singaporean men, with total PSA between 4.0 and 10 ng/ml
    Goh, Y. S. B.
    Tan, G. L. L.
    Tan, Y. K.
    Tai, B. C.
    Tan, K. M. L.
    Hawkins, R. C. W.
    Hong, F.
    Chiong, E.
    [J]. BJU INTERNATIONAL, 2015, 115 : 3 - 3
  • [27] Impact of PSA density of transition zone as a potential parameter in reducing the number of unnecessary prostate biopsies in patients with PSA levels between 2.6 and 10.0 ng/mL
    Socrates Castro, Hugo A.
    Iared, Wagner
    Mourao Santos, Jose Eduardo
    Solha, Raphael Sandes
    Shigueokal, David Carlos
    Ajzen, Sergio Aron
    [J]. INTERNATIONAL BRAZ J UROL, 2018, 44 (04): : 709 - 716
  • [28] Validation of Prostate Imaging Reporting and Data System Version 2 for the Detection of Prostate Cancer
    Hofbauer, Sebastian L.
    Maxeiner, Andreas
    Kittner, Beatrice
    Heckmann, Robin
    Reimann, Maximillian
    Wiemer, Laura
    Asbach, Patrick
    Haas, Matthias
    Penzkofer, Tobias
    Stephan, Carsten
    Friedersdorff, Frank
    Fuller, Florian
    Miller, Kurt
    Cash, Hannes
    [J]. JOURNAL OF UROLOGY, 2018, 200 (04): : 767 - 772
  • [29] Repeat prostate biopsies are required in the low PSA range 2.5-4 ng/mL
    Djavan, B
    Borkowski, A
    Dobronsky, P
    Gibod, LB
    Schulman, C
    Zlotta, A
    Ravery, V
    Seitz, C
    Marberger, M
    [J]. JOURNAL OF UROLOGY, 2002, 167 (04): : 101 - 101
  • [30] Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL
    Li, XM
    Zhang, L
    Li, J
    Li, Y
    Wang, HL
    Ji, GY
    Kuwahara, M
    Zhao, XJ
    [J]. ASIAN JOURNAL OF ANDROLOGY, 2005, 7 (03) : 323 - 328
12345